Editorial
Treatment and prognostic factor for recurrent thymic epithelial tumors
Abstract
Thymic epithelial tumors (TETs) consist of thymoma and thymic carcinoma, and they tend to be treated fairly similarly despite they are histopathologically highly heterogeneous and officially recognized to be distinct according to the update of the WHO classification in 2004 (1).
